Oncology & Cancer

Chemo ups metabolic syndrome risk in early-stage breast cancer

(HealthDay)—For patients with early-stage breast cancer with no preexisting metabolic syndrome (MetS), chemotherapy is associated with increased risk of MetS, according to a study published online May 24 in Cancer.

Oncology & Cancer

Consensus in the fight against colorectal cancer

In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, ...

page 20 from 31